Maximizing Cancer Pain Management
by Betty Ferrell, RN, PhD, MA, FAAN, FPCN, and Tami Borneman, RN, MSN, CNS, FPCN
Madeline Brown is a 42-year-old woman diagnosed with stage II ovarian cancer. She has responded well to surgery and chemotherapy and in many ways has resumed her life. However, Mrs. Brown has been experiencing pain, pelvic and vaginal discomfort, and moderate to severe peripheral neuropathy. The pain is causing significant disruption in her life. As the months progress and her pain continues, Mrs. Brown becomes anxious and depressed, and her family becomes increasingly concerned.
Drug Treatment for Cutaneous T-cell Lymphoma Approved
The U.S. Food and Drug Administration has approved Gloucester Pharmaceuticals’ Istodax® (romidepsin), an injectable medication, for treatment of people with a rare form of cancer known as cutaneous T-cell lymphoma.
Top Cancer Research Advances of 2009The American Society of Clinical Oncology has released its report Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention and Screening, an independent assessment of the most significant clinical cancer research studies of the past year, including 15 major advances. The report also makes policy recommendations for increasing investment in cancer research funding, accelerating progress in clinical cancer research, and ensuring that Americans with cancer receive high-quality care.
Why Do I Need Chemo if I’m Cancer-Free?
by Richard C. Frank, MD
No one really wants to meet with an oncologist if they don’t have to. People who undergo cancer surgery, of course, hope that the surgeon will come to their bedside after the operation and say, “Well, that’s it. I got everything; you’re cured.” In reality, many people will hear something like this: “The surgery went very well. I got all the cancer. But you should meet with an oncologist in case you need chemotherapy.” All told, nearly a third of people with cancer undergo cancer treatment after surgery as part of a plan to cure their cancer.
National Cancer Institute
Annual Progress Report 2009
by John E. Niederhuber, MD, Director, National Cancer Institute
Cancer survivors face a special challenge and a unique opportunity this year, for a number of reasons. The United States and, in fact, the world is struggling to right a financial system in turmoil, and far, far too many of our fellow citizens are unemployed or under-employed. The number of those around us who lack health insurance, including many people with cancer and cancer survivors, may now have eclipsed 50 million. Even comparatively wealthy communities in the United States are struggling to support those in need. Those survivors who need expensive medicines are challenged, now, more than ever, to find a way to pay for those drugs.
Fertility & Cancer
by Kutluk Oktay, MD, and Kenny Rodriguez-Wallberg MD, PhD
As cancer survival rates continue to improve, many young adults will face infertility after being cured from their malignant diseases. Fertility is a critical component of quality of life for cancer survivors. Given the significant impact of cancer treatments on fertility, fertility preservation should be a natural extension of cancer care.
Chronic Cancer Pain Management
by Patricia Ringos Beach, MSN, RN, AOCN, ACHPN
All pain is not created equal, but chronic cancer pain can be controlled and relieved. By controlling your pain, you free up energy to focus on enjoying your life.
Understanding Bisphosphonates in Cancer Care
by Ana Maria Lopez, MD, MPH, FACP
Bone health is significant at multiple points in the cancer journey. Cytotoxic chemotherapy may be directly harmful to osteoclasts, the cells that make bone, thereby promoting bone loss. Combined with poor oral intake, decreased physical activity, and increased body mass index, bone health is assaulted on multiple fronts by cancer therapy.